Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)
This study has been completed.
Sponsor:
Kantonsspital Aarau
Information provided by:
Kantonsspital Aarau
ClinicalTrials.gov Identifier:
NCT00426855
First received: January 24, 2007
Last updated: November 5, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |